Effects of combined treatment with recombinant bovine somatotropin and immunization with live oocysts on performance of broiler chicks raised in coccidia-seeded floor pens

Abstract

In our laboratory, preliminary studies have indicated that recombinant bovine somatotropin (rbST) can stimulate protective immunity against coccidia infection. A floor pen trial on coccidia-seeded litter was run to further test its activity as an adjuvant during immunization of chicks with a live oocyst vaccine. Five hundred day-old male broiler strain chicks were randomly assigned to five experimental Treatments: 1, medicated controls; 2, unimmunized, not treated with rbST; 3, unimmunized, rbST-treated; 4, immunized, not treated with rbST; 5, immunized, rbST-treated. Each treatment consisted of four pens of 25 chicks each. At the end of the growout period (7 wk), the chicks in Treatment 1 (medicated controls) had the highest mean BW, but mean BW of chickens in Treatment 3 (rbST treatment only) were not significantly less. On the other hand, the mean weights of chicks in Treatments 4 (immunized only) and 5 (immunized plus rbST) were significantly reduced, and not different from those of the untreated chickens (Treatment 2). However, when challenged at 3 wk, the chicks in Treatment 5 had a mean combined total lesion score that was significantly lower than that from Treatment 3, indicating that they had developed a higher degree of specific immunity, but of the expense of weight gain. The results suggest that rbST has a potential for use as an adjuvant with live oocyst vaccination, but that the ratio between rbST dose and numbers of oocysts in the live vaccine needs to be carefully controlled.